Advertisement

Topics

NCE Discovery Limited Company Profile

06:13 EDT 23rd June 2018 | BioPortfolio

nce discovery was spun out of the Wolfson Institute for Biomedical Research, University College London in 2001 and provides expert medicinal chemistry services to pharmaceutical and biotechnology companies across the UK and Europe. Our state of the art laboratories are based in Cambridge, UK, at the centre of Europe’s largest biotechnology cluster.nce discovery builds a full understanding of the client’s needs, and the technical challenges presented by biological targets of interest. The Company can support and design comprehensive chemistry programmes – from hit finding through to pre-clinical development. These programmes are designed and delivered by experienced medicinal chemists working in fully equipped laboratories, supported by expert computational chemistry using industry-leading software.

Location

418 Cambridge Science Park Milton Road
Cambridge
Cambridgeshire
CB4 0PZ
United Kingdom

Contact

Phone: 44 (0)1993 201 801
Fax: 44 (0)1993 200 401
Email: info@ncediscovery.com


News Articles [357 Associated News Articles listed on BioPortfolio]

Integrated lead discovery: An evolving toolbox

(SLAS (Society for Laboratory Automation and Screening)) A new SLAS Discovery review article by GlaxoSmithKline researchers in the US and UK offers an informative guide to the established and emerging...

How Robot Math and Smartphones Led Researchers to a Drug Discovery Breakthrough

NewsResearchers have figured out how to apply an algorithm originally designed to help robots move to an entirely different problem: drug discovery.

Beacon Discovery, Janssen team up in metabolic conditions

Beacon Discovery Inc. and Janssen Pharmaceuticals Inc. are teaming up in the discovery of small molecules aimed at various G-protein coupled receptor (GPCR) targets for metabolic diseases.

X-Chem, AstraZeneca expand drug discovery partnership

X-Chem, a small molecule discovery specialist, has expanded its existing global drug discovery and technology transfer collaboration with AstraZeneca.

The Current issue of “The view from here” is concerned with Allosterism in Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Allosterism in Drug Discovery”.

Beacon enters drug discovery collaboration with Janssen

US-based drug discovery firm Beacon Discovery has entered a multi-year collaboration agreement with Janssen Pharmaceuticals for small molecule compounds to...Read More... The post Beacon enters drug d...

Eisai accelerates dementia drug discovery research

Eisai is launching a special dementia discovery centre to boost development of next-generation medicines targeting forms of the condition, including Alzheimer’s disease. The new Center for Genetic...

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

PubMed Articles [493 Associated PubMed Articles listed on BioPortfolio]

Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.

The identification of high-quality starting points for drug discovery is an enduring challenge in medicinal chemistry. Yet, the chemical space explored in discovery programmes tends be limited by the ...

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

Challenges with modelling anxiety disorders: a possible hindrance for drug discovery.

Challenges with biomarkers in cancer drug discovery and development.

Who was Dr. William C. Baum?

The first discovery of primary hyperaldosteronism secondary to an aldosterone-secreting adrenal adenoma has been credited solely to Dr. Jerome Conn, an endocrinologist at the University of Michigan an...

Clinical Trials [170 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1169 Associated Companies listed on BioPortfolio]

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Sentinel Oncology Limited

Sentinel Oncology was founded in 2005 with the vision of developing an innovative strategy for cancer treatment, ‘Targeted Synergy’ in which a single drug can be engineered to deliver tw...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

More Information about "NCE Discovery Limited" on BioPortfolio

We have published hundreds of NCE Discovery Limited news stories on BioPortfolio along with dozens of NCE Discovery Limited Clinical Trials and PubMed Articles about NCE Discovery Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NCE Discovery Limited Companies in our database. You can also find out about relevant NCE Discovery Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record